VRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Valeant Pharmaceuticals International Inc's cash flow from others for the three months ended in Dec. 2016 was $645 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2016 was $1,810 Mil.
Valeant Pharmaceuticals International Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2016 was 96.7 (Mar. 2016 ) + -35.6 (Jun. 2016 ) + 1103.5 (Sep. 2016 ) + 645.4 (Dec. 2016 ) = $1,810 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Valeant Pharmaceuticals International Inc Annual Data
|Cash Flow from Others||93||-60||56||196||134||293||739||293||766||1,810|
Valeant Pharmaceuticals International Inc Quarterly Data
|Cash Flow from Others||-125||289||121||149||199||275||97||-36||1,104||645|